Selskabets formål er at drive virksomhed med udvikling, markedsføring og salg og distribution af produkter og serviceydelser inden for medicinsk diagnosticering og prognosticering og det farmaceutiske marked.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 5.3 mio. | -10.4 mio. | 30.6 mio. | 19.4 mio. | 7 | |
CVR: 25734033
Previous names: VICH 6186 ApS, VIROGATES ApS
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
The financial health of VIROGATES A/S shows significant challenges, with consistent losses over the past five years. Revenue peaked at 10,151,000 DKK in 2022 but has since declined to 5,307,000 DKK in 2025, while cumulative losses have resulted in a negative profit margin, reaching -10,397,000 DKK in the latest year. Despite a slight recovery in equity to 19,403,000 DKK in 2025, the ongoing losses raise concerns about sustainability and operational efficiency. The company operates within the wholesale trade of medicinal products and healthcare items, but its declining revenue trajectory and persistent profitability issues indicate a precarious position in the industry.
AI-generated summary
Companies in the same industry and area
CVR 17744038
CVR 19301540
CVR 84786217
CVR 13988102
CVR 12044976
Niels Peter Louis-Hansen registered with 25% ownership
Ginnerup Capital ApS registered with 10% ownership
N. P. LOUIS-HANSEN ApS registered with 25% ownership
BDO Statsautoriseret Revisionspartnerselskab appointed as auditor
A/S PSE 17 NR. 1056 resigned as auditor
companydata.dk